ClinicalTrials.Veeva

Menu

Trial to Evaluate the Efficacy of Fluvastatin on Certain Markers

Novartis logo

Novartis

Status and phase

Completed
Phase 4

Conditions

Dyslipidemia

Treatments

Drug: Fluvastatin

Study type

Interventional

Funder types

Industry

Identifiers

NCT00171262
CXUO320BES02

Details and patient eligibility

About

To analyze efficacy of fluvastatin on patients with chronic renal disease by analyzing certain inflammatory markers. In addition, tolerability and safety will also be evaluated in a Spanish population.

Enrollment

120 patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients > 18 years Patients that give their inform consent

Exclusion criteria

  • Pregnant women Diabetic patients Treated with statins for the year prior to study inclusion Patients with contraindications listed in fluvastatin prescribing information

Other protocol-defined in and exclusion criteria may apply

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems